CRISPR Therapeutics AG (CRSP) Fundamentals
CRISPR Therapeutics AG (CRSP) fundamentals on the US markets. Fundamentals360 brings together a fair value estimate from a set of valuation models, valuation multiples, dividend history and yield, income statement, balance sheet and cash flow, a capital score, and a peer comparison, so you can judge whether CRSP looks cheap or expensive versus its own history and its peers.
See the full CRSP fundamentals, fair value, and dividends on Portfolio360.